Post-transplant lymphoproliferative disorder, early lesion (Q39453): Difference between revisions

← Older edit

@@ Property / Canonical URI @@
+https://id.who.int/icd/entity/713946165
@@ Property / Canonical URI: https://id.who.int/icd/entity/713946165 / rank @@
+Normal rank
@@ Property / CURIE @@
+CID11:2B32.0
@@ Property / CURIE: CID11:2B32.0 / rank @@
+Normal rank
@@ Property / Canary Token @@
+dki-india-2B32.0
@@ Property / Canary Token: dki-india-2B32.0 / rank @@
+Normal rank
@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-13T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-13T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 13 August 2026 / rank @@
+Normal rank
@@ Property / Linked ICD 10 @@
+D47.7
@@ Property / Linked ICD 10: D47.7 / rank @@
+Normal rank

Latest revision as of 04:52, 13 August 2026

A lymphoproliferative disorder arising as a result of post-transplant immunosuppression therapy. It is characterised by the lack of tissue destruction and the architectural preservation of the involved tissues. It includes two morphologic variants: plasmacytic hyperplasia and infectious mononucleosis-like lymphoproliferative disorders.

Language	Label	Description	Also known as
default for all languages	2B32.0
English	Post-transplant lymphoproliferative disorder, early lesion	A lymphoproliferative disorder arising as a result of post-transplant immunosuppression therapy. It is characterised by the lack of tissue destruction and the architectural preservation of the involved tissues. It includes two morphologic variants: plasmacytic hyperplasia and infectious mononucleosis-like lymphoproliferative disorders.